Immunoprecise Antibodies Ltd (IPA) — Strategic Asset Allocation Index
Immunoprecise Antibodies Ltd (IPA) has a Strategic Asset Allocation Index of 0.0% as of April 2024. Strategic assets (PP&E of $- plus long-term investments of $0.00) total $0.00, measured against net assets of $33.92 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check how resilient are Immunoprecise Antibodies Ltd's assets to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Immunoprecise Antibodies Ltd Strategic Asset Allocation Index (2017–2024)
This chart shows how Immunoprecise Antibodies Ltd's Strategic Asset Allocation Index has evolved across 8 annual periods from 2017 to 2024. As of April 2024, the index stands at 0.0%, representing strategic assets of $0.00 against net assets of $33.92 Million USD. See IPA financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Immunoprecise Antibodies Ltd (2017–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for Immunoprecise Antibodies Ltd from 2017 to 2024, covering 8 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Immunoprecise Antibodies Ltd stock valuation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 0.0% | $0.00 | $- | $0.00 | $33.92 Million | ▼ -18.2 pp |
| 2023 | 18.2% | $10.51 Million | $10.39 Million | $115.00K | $57.80 Million | ▲ +13.6 pp |
| 2022 | 4.6% | $3.48 Million | $3.34 Million | $142.00K | $75.28 Million | ▼ -2.6 pp |
| 2021 | 7.3% | $4.13 Million | $4.02 Million | $111.00K | $56.92 Million | ▼ -13.8 pp |
| 2020 | 21.1% | $3.18 Million | $3.06 Million | $118.90K | $15.09 Million | ▲ +12.0 pp |
| 2019 | 9.1% | $1.65 Million | $1.56 Million | $90.40K | $18.07 Million | ▼ -4.0 pp |
| 2018 | 13.1% | $1.67 Million | $1.58 Million | $90.40K | $12.70 Million | ▼ -7.7 pp |
| 2017 | 20.8% | $644.58K | $644.58K | $- | $3.09 Million | — |